Sep 11, 2023 09:41AM

Sep 7, 2023 09:00AM

Aug 28, 2023 08:00AM

Aug 11, 2023 08:00AM

Aug 8, 2023 08:00AM

Jul 26, 2023 08:00AM

Jul 10, 2023 05:19PM Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Jun 27, 2023 08:04AM

Jun 27, 2023 08:00AM

Jun 21, 2023 08:04AM

Jun 21, 2023 08:00AM

Jun 12, 2023 08:04AM

Jun 12, 2023 08:00AM

May 24, 2023 04:05PM Ocuphire Pharma, Inc. Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

May 15, 2023 08:00AM

May 2, 2023 08:30AM

Apr 25, 2023 08:00AM

Apr 21, 2023 08:00AM

Apr 21, 2023 08:00AM

Mar 30, 2023 08:00AM

Mar 23, 2023 08:00AM Ocuphire Announces APX3330 and Nyxol® Data Presentations at ARVO 2023 Annual Meeting

Feb 16, 2023 08:30AM

Feb 13, 2023 08:02AM

Feb 13, 2023 08:00AM

Nov 4, 2022 04:30PM

Sep 12, 2022 08:04AM

Sep 12, 2022 08:00AM

15,423 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All